DashboardAll companies
Run this on your own research
Healthcare · Diagnostics & Research

Agilent Technologies Inc.

ANYSE$173.07−$0.82 (−0.47%)Market closed

Price Chart

Daily

Key facts

Market Cap
$48.81B
P/E
37.7x
P/B
7.29x
ROE
20.6%

Agilent Technologies Inc.

Healthcare · Diagnostics & Research · FY 2025

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

CEO
Mr. Padraig McDonnell
Employees
18,000

Company Statistics

Valuation

P/E
37.7x
P/B
7.29x
P/S
7.07x
EV/EBITDA
27.6x
P/FCF
42.7x

Margins

Gross
52.4%
EBITDA
26.4%
Operating
21.3%
Pre-Tax
20.7%
Net
18.8%

Returns

ROA
10.6%
ROE
20.6%
ROIC
12.6%

Growth (CAGR)

Rev 3Yr
0.5%
Rev 5Yr
5.4%
Op Inc 3Yr
−2.9%
Net Inc 3Yr
1.3%

Financial Health

Cash & Cash Equivalents
$1.79B
Net Debt
$4.20B
Debt/Equity
88.8%
Interest Cov
—

Profile

Revenue
$6.95B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Agilent Technologies Inc. (A) Stock Forecast 2026 $173.07 — Price, Financials & Analyst Targets | AlphaLenz